Rescue medication is acetaminophen, 325mg tablets, one to two tablets per dose, every six hours, as needed, up to six tablets (1 ,950 mg/24 hour day). Subjects who have been on a stable, approved dose of gabapentin are eligible for enrollment, but are required to continue their gabapentin dose regimen throughout the study.